NOVAtest LOGO

Menu Search

Multi-Drug Urine Screening Panels

Our multi-drug test panels identify specific drugs of abuse in urine specimen with high sensitivity and specificity.

DOA Multi Drug Dip test panel

Multi-drug Test Panels

DOA urine screening test panels are qualitative lateral flow chromatographic immunoassay test devices, based on the principle of drug-competitive inhibition immunoassay, employing unique monoclonal antibodies to selectively identify specific drugs of abuse (DOA) and the corresponding metabolites in urine samples with high sensitivity and specificity.

CE Marked Drug Test

Atlas Link Technology Co., Ltd supplies CE marked drug urine screening test kits in the formats of strip, cassette and multi-drug test panel with the following merits:

  • Highly sensitive and specific;
  • DOA testing results are read visually;
  • No extra reagent is needed;
  • Combinations subject to customers' selection.

Drug Competitive Immunoassay Principle

When testing with a rapid drug urine test, if the target drug and its metabolites present, they will compete with the colloidal gold labeled color developing chemicals for the binding site on the immobilized antibody in the test line region; when the concentration of the drug and its metabolites reach the cut-off level of the testing kit, they leave no binding site to the latter, and no color develops at the testing line, indicating a positive result.

Illustration of Ordering

1. Multi drug test panels up to 10 Parameters are available; combinations subject to Custom Choice from all the drugs show in the table of "Multi-drug Test Parameters".

2. For single drug test, please check and search in another page for drug test strip and cassette formats.

Multi-drug Test Parameters

No. Abbr. Full Name Cut-off (ng/ml)
1 AMP Amphetamine 1000
2 BAR SecoBarbital 300
3 BUP Buprenorphine 10
4 BZO Oxazepam Benzodiazepines 300
5 COC Cocaine 300
6 COT Cotinine 200
7 EDDP ethylenediamine-dimethyl phosphinic acid 100
8 FYL Fentanyl 200
9 K2 Synthetic Cannabis 50
10 KET Ketamime 1000
11 LSD Lysergic acid diethylamide 50
12 MDMA Ecstasy 500
13 MET Methamphetamine 1000
14 MOR Morphine 300
15 MQL Methaqualone 100
16 MTD Methadone 300
17 OPI Opiates Morphine 2000
18 OXY Oxycodone 100
19 PCP Phencyclidine 25
20 PPX Propoxyphene 300
21 TCA Tricyclic Antidepressants 1000
22 THC Marijuana 50
23 TML Tramadol 100

Add Multi-Drug Test Panels to Inquiry List.

Cat. No. Select Combination Specimen PCS/Box Quan. per CTN Quantity (Tests)
DOA 602 urine 25 Bulk: 1600 PCS
Boxed: 40 Boxes
DOA 603 urine 20 Bulk: 1000 PCS
Boxed: 32 Boxes
DOA 604 urine 20 Bulk: 1000 PCS
Boxed: 32 Boxes
DOA 605 urine 20 Bulk: 1000 PCS
Boxed: 32 Boxes
DOA 606 urine 20 Bulk: 1000 PCS
Boxed: 32 Boxes
DOA 610 urine 20 Bulk: 1000 PCS
Boxed: 32 Boxes
How to Use

AMP Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:AMP 611
Description:AMP Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96.3%
Specificity:94.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

AMP Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:AMP 612
Description:AMP Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96.3%
Specificity:94.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BAR Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BAR 621
Description:BAR Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:92.4%
Specificity:97.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BAR Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BAR 622
Description:BAR Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:92.4%
Specificity:97.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BUP Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BUP 6041
Description:BUP Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:10
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BUP Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BUP 6042
Description:BUP Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:10
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BZO Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BZO 631
Description:BZO Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96.3%
Specificity:96.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

BZO Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:BZO 632
Description:BZO Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96.3%
Specificity:96.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

COC Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:COC 641
Description:COC Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96%
Specificity:90.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

COC Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:COC 642
Description:COC Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96%
Specificity:90.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

COT Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:COT 6091
Description:COT Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:200
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96%
Specificity:90.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

COT Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:COT 6092
Description:COT Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:200
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:96%
Specificity:90.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 2P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 602
Description:DOA 2P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 3P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 603
Description:DOA 3P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:20 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:32 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):17.5 KG

Materials Provided in the Test Kit

  • Test card in individual foil pouch;
  • Package insert;
  • Disposable urine container (Optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 4P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 604
Description:DOA 4P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:20 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:32 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):17.5 KG

Materials Provided in the Test Kit

  • Test card in individual foil pouch;
  • Package insert;
  • Disposable urine container (Optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 5P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 605
Description:DOA 5P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:20 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:32 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):17.5 KG

Materials Provided in the Test Kit

  • Test card in individual foil pouch;
  • Package insert;
  • Disposable urine container (Optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 6P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 606
Description:DOA 6P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:20 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:32 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):17.5 KG

Materials Provided in the Test Kit

  • Test card in individual foil pouch;
  • Package insert;
  • Disposable urine container (Optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

DOA 10P Urine Screening Panel

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:DOA 610
Description:DOA 10P Urine Screening Panel
Category:Substance Abuse
Style:Panel
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:Ref. to single drug
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:20 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:32 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):17.5 KG

Materials Provided in the Test Kit

  • Test card in individual foil pouch;
  • Package insert;
  • Disposable urine container (Optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

EDDP Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:EDDP 6101
Description:EDDP Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

EDDP Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:EDDP 6102
Description:EDDP Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:4.0 mm
Quan. or Qual.:Semi-Quantitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

FYL Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:FYL 6131
Description:FYL Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:200
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

FYL Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:FYL 6132
Description:FYL Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:200
Specification:4.0 mm
Quan. or Qual.:Semi-Quantitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

K2 Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:K2 6061
Description:K2 Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

K2 Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:K2 6062
Description:K2 Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

KET Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:KET 6051
Description:KET Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

KET Urine Screening Card

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:KET 6052
Description:KET Urine Screening Card
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

LSD Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:LSD 6071
Description:LSD Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

LSD Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:LSD 6072
Description:LSD Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:
Specificity:
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MDMA Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MDMA 651
Description:MDMA Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:500
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MDMA Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MDMA 652
Description:MDMA Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:500
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:99.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

mAMP Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MET 661
Description:mAMP Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.3%
Specificity:92.7%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

mAMP Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MET 662
Description:mAMP Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.3%
Specificity:92.7%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MOR Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MOR 671
Description:MOR Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:94.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MOR Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MOR 672
Description:MOR Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:94.3%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MQL Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MQL 6141
Description:MQL Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.2%
Specificity:94.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MQL Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MQL 6142
Description:MQL Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.2%
Specificity:94.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MTD Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MTD 681
Description:MTD Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.2%
Specificity:94.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

MTD Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:MTD 682
Description:MTD Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:99.2%
Specificity:94.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

OPI Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:OPI 691
Description:OPI Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:2000
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:90.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

OPI Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:OPI 692
Description:OPI Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:2000
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:90.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

OXY Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:OXY 6111
Description:OXY Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:90.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

OXY Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:OXY 6112
Description:OXY Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:90.4%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

PCP Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:PCP 6011
Description:PCP Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:25
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:96.9%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

PCP Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:PCP 6012
Description:PCP Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:25
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:96.9%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

PPX Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:PPX 6121
Description:PPX Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:96.9%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

PPX Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:PPX 6122
Description:PPX Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:300
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:100%
Specificity:96.9%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

TCA Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:TCA 6021
Description:TCA Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.8%
Specificity:95%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

TCA Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:TCA 6022
Description:TCA Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:1000
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.8%
Specificity:95%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

THC Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:THC 6031
Description:THC Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

THC Urine Screening Cassette

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:THC 6032
Description:THC Urine Screening Cassette
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:50
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

Tramadol Urine Screening Strip

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:TML 6081
Description:Tramadol Urine Screening Strip
Category:Substance Abuse
Style:Dipstick
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:3.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:100 Tests
Box Dimension:21.0 * 12.5 * 5.5 CM
Kits per CTN:48 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):6000 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):15.0 KG
GW per CTN (Bulk):16.0 KG

Materials Provided in the Test Kit

  • Lateral Flow immunochromatographic assay (GICA) Strip;
  • Instruction leaflet;
  • Disposable urine cup (optional).

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle

Tramadol Urine Screening Card

General Information

(IVD Kit »-» Substance Abuse -» One Step Lateral Flow Immunochromatographic Assay)

Catalog No.:TML 6082
Description:Tramadol Urine Screening Card
Category:Substance Abuse
Style:Card
Unit:PCS
Specimen:urine
No. of Step:One Step
Reading Time:5 Minutes
Cut Off:100
Specification:4.0 mm
Quan. or Qual.:Qualitative
Sensitivity:97.5%
Specificity:86.5%
Method:Lateral Flow Competitive Binding

Packing Specification

Tests per Kit:25 Tests
Box Dimension:21.0 * 12.5 * 6.5 CM
Kits per CTN:40 Kits
Carton Dimension:53 * 45 * 36 CM
Tests per CTN (BULK):1600 Tests
Carton Volume:0.085 CBM
GW per CTN (Boxed):14.0 KG
GW per CTN (Bulk):16.5 KG

Materials Provided in the Test Kit

  • Test cassette in single foil pouch with desiccant;
  • Disposable sample dropper;
  • Instruction leaflet.

Specimen

Urine Collection

A urine specimen must be collected in a clean and dry container.

For hormone test such as HCG prenancy test, the first urine specimen in the morning is preferred since it generally contains the highest concentration of hormone, although urine specimens collected at any time of the day may be used.

Urine specimens exhibiting visible particles should be centrifuged, filtered, or allowed to settle to obtain clear specimen for testing.

urine Storage Condition

Urine specimens may be stored at 2-8°C for up to 48 hours prior to testing. For long-term storage, specimens may be frozen and stored below -20°C.

Frozen specimens should be thawed and mixed before testing.

Testing Principle of Lateral Flow Competitive Binding

GICA Competitive Method Illustration

Drug abuse test kits are based on the Lateral Flow Competitive Binding rapid test principle.

In the test kit, drug-protein conjugates (purified bovine albumin) are immobilized in the test line region. And the drug specific antibody conjugated with colloidal gold particles is put in the membrane of the sample adding region.

During testing, when the urine specimen is added to the sample adding region, the antibody conjugate particles will come into the urine specimen, where the antibody conjugate will react with the drug. If there is no target drug in the urine specimen, or the concentration is lower than the cut-off, the drug can not bind all the binding sites of the drug specific antibody colloidal gold conjugate.

The unbonded colloidal gold conjugate will be captured by the immobilized drug in the testing line region. When the antibody conjugated colloidal gold particle congregate, a red or pink color will develop, indicating a negative result.

If the concentration of the drug is higher than the cut off value of the test kit, the drug will saturate all the binding sites of the antibody conjugate. Then, when the mixed fluid moves to the test region under capillary effect, there will be no free antibody particles to bind with the immobilized drug, and no color will develop, indicating a positive result.

Information | Packing | Specimen | Principle